UNITED STATES PATENT AND TRADEMARK OFFICE
`UN_lTED STATES DEPARTMENT OF COMNIERCE
`United States Patent and Trademark Ofiice
`Address: COMMISSIONER FOR PATENTS
`P.0. Box 1450
`Alexandria. Virginia 2313-1450
`www:nspIo.gov
`
`APPLICATION N0.
`
`13/132,996
`
`ISSUE DATE
`
`08/06/2013
`
`PATENT NO.
`
`ATTORNEY DOCKET N0.
`
`CONFIRMATION NO.
`
`8501799
`
`0333391406015
`
`961 5
`
`826
`
`7590
`
`07/17/2013
`
`3 ALSTON & BIRD LLP
`BANK OF AMERICA PLAZA
`101 SOUTH TRYON STREET, SUITE 4000
`CHARLOTTE, NC 28280-4000
`
`The projected patent number and issue date are specified above.
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above-identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that
`determines Patent. Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEB site (http://pair.uspto.gov).
`
`Any questions regarding the Patent Tenn Extension or Adjustment determination should be directed to the
`Office of Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee
`payments should be directed to the Application Assistance Unit (AAU) of the Office of Data Management
`(ODM) at (571)-272-4200.
`
`APPLICANT(S) (Please see PAIR WEB site httpzi/pair.uspto.gov for additional applicants):
`
`Guy Derrieu, Cagnes Sur Mer, FRANCE;
`
`The United States represents the largest, most dynamic marketplace in the V
`for business investment, innovation, and commercialization of new techno
`IPR2014'01279
`resources and advantages for those who invest and manufacture goods he
`works to encourage and facilitate business investment. To learn more about ,. __, ___ _ __ - -- --- ---- -e......, ...
`the world to develop technology, manufacture products, and grow your business, visit §e1§gt[J§A.gov.
`
`Merial V. Virbac
`
`Exhibit 1002A
`
`111103 (Rev. 10/09)
`
`1002A.000001
`
`

`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`‘QIIAM
`
`.-1*‘
`
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Tradark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria. Virginia 2Bl3-1450
`www.nspIo.gov
`
`APPLICATION NO.
`
`13/132,996
`
`ISSUE DATE
`
`08/06/2013
`
`PATENT NO.
`
`8501799
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`033339/406015
`
`9615
`
`826
`
`7590
`
`07/170013
`
`E ALSTON & BIRD LLP
`BANK OF AMERICA PLAZA
`101 SOUTH TRYON STREET, SUITE 4000
`CHARLOTTE, NC 28280-4000
`
`The projected patent number and issue date are specified above.
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above-identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that
`determines Patent. Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Rettieval (PAIR) WEB site (http://pair.uspto. gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the
`Office of Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee
`payments should be directed to the Application Assistance Unit (AAU) of the Office of Data Management
`(ODM) at (571)-272-4200.
`
`APPLICANT(S) (Please see PAIR WEB site httpzi/pair.uspto.gov for additional applicants):
`
`Guy Derrieu, Cagnes Sur Mer, FRANCE;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit §elect[1§A.gov.
`
`1R1o3(ReV_ 10/09)
`
`1002/XOOOOO1
`
`

`
`PART B - FEE(S) TRANSMITTAL
`
`GRRBWCORRESPONDEJCE ADDRESS (Now liselilodz 1 fotanychanssofndchssi
`
`Complete and send this fomi, together with applicable t‘ee(s), to: Mail Mail Stop ISSUE FEE
`Commissioner for Patents
`P.O. 39;: 1450
`Alexandria, Virginia 22313-1450
`or @ (571)-273-2885
`lNSTR1:lC'l’lO.\'S: This form should be_ used_t'or transmitting the ISSUE FEE and _PUB_LICATlON FEE (if required). Blocks 1
`through 5 should be completed where
`ap _opriate. All further concspondcncc including the Patent. advance orders aiid_notificrition of maintenance l'ccs will be mailed to the current corrcsfizondcncc address as
`main nance een iica ions.
`in icated unlte_ss cgilrrtectelzd below or directed otherwise in Block 1, by (a) specifying a new correspondence address; andlor (h) indicating a separate "
`.E ADDRESS” for
`Note: A certificate of mailinig can only be used for domestic mailings of the
`Fee(s) Transmittal. This certi icate cannot be used for any other accompanying
`papers. Each additional paper. such as an assignment or formal drawing. must
`ave its own certificate of mailing or transmission.
`Certificate at Mailing or Transmission
`that this Fe ()'r
`'ttal' be"
`d
`‘ted
`iii
`b-oe '
`‘uni. U ‘ted
`55:1: cgtarllgjfimff
` ge:E'g flilgtilfzigglmailllieii an gnvgllatie
`C l
`8.1
`0
`" 3
`POSS 3 V8, of
`3
`SS3
`[0
`H1
`3CSlfl'llC
`‘
`"
`transrnitted to the USPTO( 71) 273-2885, on the date indicated belgw.
`
`CHARLOTTE, NC 28280-4000
`
`APPLICATION NO.
`
`HLING DATE
`
`FIRST NAME) INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION N0.
`
`0333391406015
`Guy Derrieu
`08/ l7/2011
`l3/132.996
`TITLE OF INVENTION: Pharmaceutical Composition Containing An N-Phenylpyrazole Derivative. And Use Thereof For Preparing A Topical Veterinary
`For Flea Control
`
`9615
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEB DUE
`
`nonprovlsionzil
`
`UNDISCOUNIED
`
`51780
`
`PUBLICATION FEE DUE PREV. PAID ISSUE FEE
`3300
`$0
`
`TOTAL l’-'EE(S] DUE
`
`DATE DUE
`
`52080
`
`07/05/2013
`
`NEAGU. IRINA
`
`1627
`
`CW3-W3C‘-ASS
`5l4—407000
`
` 2. For printing on the patent front page. list
`1. Chan e of correspondence address or indication of "Fee Address" (37
`
`CPR l. 63).
`(1) the names of up to 3 registered patent attorneys l
`or agents OR. alternatively,
`ndence address (or Change of Correspondence
`e of corres
`D Cha
`I122) attached.
`Address orm PTOI
`(2) the name of a single firm (having as ii member a -
`rcgistxed attorney or agent) and the mines of up to
`
`0 "Fee Address" indication (or "Fer: Address" Indication form
`Zn: ' tered
`e tattorneysora ents.Ifnonarneis
`PTO/SB/47; Rev 03-02 or more recent) attached. Use of a Customer
`3
`listeasno nafi vliill be printed. g
`Number is required.
`
`
`
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`
`
`
`PLEASE NOTE: Unless an iissi nee is identified below, no assignee data will appear on_ the patent. [fan assignee is identified below, the document has been filed for
`reoordation as set forth in 37 C
`3.11. Completion of this form is NOT a substitute for filing an assignment.
`(A) NAME OF ASS IGNEE
`(B) RESIDENCE: (CITY and STATE OR COUNTRY)
`
`VIRBAC
`
`Carros , France
`
`Please check the appropriate assignee category or categories (will not be printed on the patent) : 0 individual Kniorporation or other private group entity El Government
`
`4b. Payment of Fee(s'): (Please first reapply any previously paid issue fee shown above)
`4a. The following l'ee(s) are submitted:
`D A check is enclosed.
`)3 Issue Fee
`D Payment by credit card. Form PTO-2038 is attached.
`H Publication Fee (No small entity discount permitted)
`D Ade-am-,5 or-dgf . # of copies
`uihe Director is hereby authorized to charge the re uired fee(s), any deficiency. or crcdit_a.ny
`overpayment, to Deposit Account Number I 6-I lfil I 5
`(enclose an extra. copy of this fonn).
`
`
`”°"”““°"°”“’
`
`Page 2 of 4
`
`1002A.0O00O2
`
`32‘
`759°
`ALSTON & BIRD LLP
`BANK OF AMERICA PLAZA
`101 SOUTH TRYON STREET, SUITE 4000
`
`°“’°4’2°‘3
`
`

`
`5. Change in Entity Status (from status indicated above)
`C] Applicant certifying micro entity status. See 37 CFR 1.29
`D Applicant asserting small entity status. See 37 CFR L27
`
`Absent a valid certification of Micro Entity Status (see form PTOISBI 15A and 15B). issue
`in: payment in the micro entity amount will not be accepted at the risk of application abandonment.
`I‘_I_QIf,_: If the application was previously under micro entity status, checking this box will be taken
`to be it notification of loss of entitlement to micro entity status.
`
`11013; Checking this box will be taken to be a notification of loss of entitlement to small or micro
`D Applicant changing to regular undiscounted fee status.
`entity status, as applicable.
`NOTE: The Issue Fee and Publication Fce (if required) will not be accepted from anyone other than the applicant: n registered iittomcy or agent: or the assigncc or other party in
`interest as shown h the records of the United States Patent and Trademark Office.
`
`June 24’ 2013
`Date
`; ‘-2- :
`N»
`-4-
`Authorized Signature
`Typed or printed name
`51 , 429
`Rcgismmon Na
`Timothy J. Balts
`
`This collection of information is required by 37 CFR 1.31 1. The information is re uired to obtain or retain a benefit by the public which 15 to file (and by the USPTO to process)
`an application. Confidentiality is governed by 35 US.C. I22 and 37 CFR H4.
`is collection is estimated to take 12 minutes to complete, including gathering. preparing, and
`submitting the completed application fon-n to the USPTO. Time will v
`7 de
`ndin upon the individual case. Any comments on the amount of time you require to oomplltge
`this form and/or suggestions for reducing this burden, should be sent to
`e
`icf
`urination Officer, U.S. Patent and Trademzirk Office. U.S. Department of Commerce,
`Box 1450. Alexan rta, Virginia 22313-1450. DO NOTSENDFFJ:".S OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, PO. Box i450.
`Alexandria. Virginia 22313-1450.
`Under the Paperwork Reduction Act of 1995. no persons are required. to respond to 21 collection of information unless it displays a valid OMB control number.
` :——
`
`
`
`PTOL-85 (Rev. 02/1 1) Approved for use through 08/31/2013.
`
`U.S. Patent and Trademadc Office; U.S. DEPARTMENT OF CONIMERCE
`OMB 065 l-W33
`1002A.OOOO03
`
`Page 3 of 4
`
`

`
`
`
`Electronic Patent Application Fee Transmittal
`
`
`
`Filing Date:
`
`17-Aug-2011
`
`Title of Invention:
`
` Pharmaceutical Composition Containing An N-Phenylpyrazole Derivative,
`And Use Thereof For Preparing A Topical Veterinary For Flea Control
`
`
`
`
`
`
`
`
`Donald Merton Hill/Joyce Smith
`
`
`
`
`
`
`
`
`
`
`
`
`Filed as Large Entity
`
`U.S. National Stage under 35 USC 371 Filing Fees
`
`
`
`
`
`Miscellaneous—Filing:
`
`Patent-Appeals-and-Interference:
`
`
` Post-AlIowance-and—Post-Issuance:
`
`
`1
`
`Utility Appl Issue Fee
`
`Publ. Fee- Early, Voluntary, or Normal
`
`

`
`Sub—Tota| in
`
`USD($)
`
`2080
`
`
`
`Total in USD ($)
`
`
`
`Extension-of—Time:
`
`
`
`1002A.00OO05
`
`

`
`
`
`T—
`
`Electronic Acknowledgement Receipt
`
`Title of Invention:
`
`Pharmaceutical Composition Containing An N-Phenylpyrazole Derivative,
`And Use Thereof For Preparing A Topical Veterinary For Flea Control
`
`
`
`
`
`
`
`
`
`“
`
`
`
`
`
`
`
`
`
`Payment information:
`Submmedwwavmem
`Payment Type
`Deposit Account
`Pavmentwassu<<essfu"vreceivedinRAM
`RAM confirmation Number
`
`
`
`
`
`
`
`
`
`
`
`.
`Deposit Account
`.
`A"th°"zed“se'
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`
`
`
`
`Charge any Additional Fees required under 37 C.F.R. 1.492 (National application filing, search, and examination fees)
`
`
`pplication and reexamination processing fees) Charge any Additional Fees required under 37 CPR. -
`
`
`
`
`
`

`
`Charge any Additional Fees required under 37 C.F.R. Section 1.19 (Document supply fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.20 (Post Issuance fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.21 (Miscellaneous fees and charges)
`
`File Listing:
`
`Document
`
`Information:
`
`Information:
`
`.
`
`.
`
`.
`
`File Size(Bytes)I
`
`Multi
`
`Pages
`
`Issue Fee Payment (PTO-85B)
`
`lSSUEFEE406015.PDF
`
`111361
`
`le7f60d2dfT7cK)07d0Bd6b88a55011d?53
`5416
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`012f4d3Sba8adlbfl9dee36be1b9S913m34
`M2
`
`‘°*°' '‘*''*= Si" "" ‘W’
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`’
`
`New Applications Ugder 35 U.§.C. 1 1 1
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCTIDO/E0/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New lnterpatiopal Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 1 1 and MPEP 1 810), a Notification of the lntemational Application Number
`and of the International Filing Date (Form PCT[ROI1 05) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`1002A.O0O007
`
`

`
`
`
`W
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNTTED STATFZS DEPA RTMKVT OF COMMERCE
`United States Patent and Trademark Office
`Addmu: COMMISSIONER I-‘OR PATENTS
`PO. Box I150
`A1exandxin,V5m‘nia 2231:4450
`wwwmpingov
`
`APPLICATION
`NUMBEK
`
`FILING or
`371(c) DATE
`
`GRP ART
`UNIT
`
`FIL FEE RECD
`
`13/132,996
`
`08/17/2011
`
`1627
`
`1110
`
`_
`
`826
`ALSTON & BIRD LLP
`aw oF AMen«cA MA
`101 SOUTH TRYON STREET, SUITE 4000
`CHARLOTTE, NC 28280-4000
`
`A'I'I'Y.DOCKET.NO
`
`033339/406015
`
`TOT CLAMS IND CLAIMS
`20
`1
`CONFIRMATION NO. 9615
`
`CORRECTED FILING RECEIPT
`
`ulllluullllllllmllmlllggllllllllllllllllll
`
`Date Mailed: 04/22/2013
`
`Receipt is acknowledged of this non-provisional patent application. The application will be taken up for examination
`in due course. Applicant will be notified as to the results of the examination. Any correspondence concerning the
`application must include the following identification information: the U.S. APPLICATION NUMBER, FILING DATE,
`NAME OF APPLICANT, and TITLE OF INVENTION. Fees transmitted by check or draft are subject to collection.
`Please verify the accuracy of the data presented on this receipt. if an error is noted on this Filing Receipt, please
`submit a written request for a Filing Receipt Correction. Please provide a copy of this Filing Receipt with the
`changes noted thereon. It you received a "Notice to File Missing Parts" for this application, please submit
`any corrections to this Filing Receipt with your reply to the Notice. When the USPTO processes the reply
`to the Notice, the USPTO will generate another Filing Receipt incorporating the requested corrections
`
`|nventor(s)
`
`Applicant(s)
`
`Guy Derrieu, Cagnes Sur Mer, FRANCE;
`
`Guy Derrieu, Cagnes Sur Mer, FRANCE;
`
`Power of Attorney: The patent practitioners associated with Customer Number 00825
`
`Domestic Priority data as claimed by applicant
`This application is a 371 of PCT/FR08/01756 12/16/2008
`
`Foreign Applications for which priority is claimed (You may be eligible to benefit from the Patent Prosecution
`Highway program at the USPTO. Please see hnp:[e.u§ptg.gov for more information.) - None.
`Foreign application information must be provided in an Application Data Sheet in order to constitute a claim to
`foreign priority. See 37 CFR 1.55 and 1.76.
`
`If Required, Foreign Filing License Granted: 08/25/2011
`
`The country code and number of your priority application, to be used for filing abroad under the Paris Convention,
`is US 1 3/132,996
`
`Projected Publication Date: Not Applicable
`
`Non-Publication Request: No
`
`Early Publication Request: No
`
`page1of3
`
`1002A.0OO008
`
`

`
`Tltle
`
`Pharmaceutical Composition Containing An N~Phenylpyrazole Derivative, And Use Thereof For
`Preparing A Topical Veterinary For Flea Control
`
`Prellmlnary Class
`
`514
`
`Statement under 37 CFR 1.55 or 1.78 for AlA (Flrst Inventor to File) Transition Applications:
`
`PROTECTING YOUR INVENTION OUTSIDE THE UNITED STATES
`
`Since the rights granted by a U.S. patent extend only throughout the territory of the United States and have no
`effect in a foreign country, an inventor who wishes patent protection in another country must apply for a patent
`in a specific country or in regional patent offices. Applicants may wish to consider the filing of an international
`application under the Patent Cooperation Treaty (PCT). An international (PCT) application generally has the same
`effect as a regular national patent application in each PCT-member country. The PCT process simplifies the filing
`of patent applications on the same invention in member countries, but does not result in a grant of "an international
`patent" and does not eliminate the need of applicants to file additional documents and fees in countries where patent
`protection is desired.
`
`Almost every country has its own patent law, and a person desiring a patent in a particular country must make an
`application for patent in that country in accordance with its particular laws. Since the laws of many countries differ
`in various respects from the patent law of the United States, applicants are advised to seek guidance from specific
`foreign countries to ensure that patent rights are not lost prematurely.
`
`Applicants also are advised that in the case of inventions made in the United States, the Director of the USPTO must
`issue a license before applicants can apply for a patent in a foreign country. The filing of a U.S. patent application
`serves as a request for a foreign filing license. The application's filing receipt contains further information and
`guidance as to the status of applicant's license for foreign filing.
`
`Applicants may wish to consult the USPTO booklet, "General Information Concerning Patents" (specifically, the
`section entitled "Treaties and Foreign Patents") for more information on timeframes and deadlines for filing foreign
`patent applications. The guide is available either by contacting the USPTO Contact Center at 800-786-9199, or it
`can be viewed on the USPTO website at http://wvvw.uspto.gov/web/offices/pac/doc/general/index.html.
`
`For information on preventing theft of your intellectual property (patents, trademarks and copyrights), you may wish
`to consult the U.S. Government website, httpj/www.stopfakes.gov. Part of a Department of Commerce initiative.
`this website includes self-help "toolkits" giving innovators guidance on how to protect intellectual property in specific
`countries such as China, Korea and Mexico. For questions regarding patent enforcement issues, applicants may
`call the U.S. Government hotline at 1-866-999-HALT (1-866-999-4158).
`
`page2of3
`
`1002A.0OOOO9
`
`

`
`LICENSE FOR FOREIGN FILING UNDER
`
`Title 35, United States Code, Section 184
`
`Title 37, Code of Federal Regulations, 5.11 & 5.15
`
`§flAN 1 ED
`
`The applicant has been granted a license under 35 U.S.C. 184, if the phrase "lF REQUIRED, FOREIGN FILING
`LICENSE GRANTED" followed by a date appears on this form. Such licenses are issued in all applications where
`the conditions for issuance of a license have been met, regardless of whether or not a license may be required as
`set forth in 37 CFR 5.15. The scope and limitations of this license are set forth in 37 CFR 5.15(a) unless an earlier
`license has been issued under 37 CFR 5.15(b). The license is subject to revocation upon written notification. The
`date indicated is the effective date of the license, unless an earlier license of similar scope has been granted under
`37 CFR 5.13 or 5.14.
`
`This license is to be retained by the licensee and may be used at any time on or after the effective date thereof unless
`it is revoked. This license is automatically transferred to any related applications(s) filed under 37 CFR 1.53(d). This
`license is not retroactive.
`
`The grant of a license does not in any way lessen the responsibility of a licensee for the security of the subject matter
`as imposed by any Government contract or the provisions of existing laws relating to espionage and the national
`security or the export of technical data. Licensees should apprise themselves of current regulations especially with
`respect to certain countries, of other agencies, particularly the Office of Defense Trade Controls, Department of
`State (with respect to Arms, Munitions and Implements of War (22 CFR 121-128)); the Bureau of Industry and
`Security, Department of Commerce (15 CFR parts 730-774); the Office of Foreign AssetsControI, Department of
`Treasury (31 CFR Parts 500+) and the Department of Energy.
`
`NOT GRANTED
`
`No license under 35 U.S.C. 184 has been granted at this time, if the phrase "IF REQUIRED, FOREIGN FILING
`LICENSE GRANTED" DOES NOT appear on this form. Applicant may still petition for a license under 37 CFR 5.12,
`if a license is desired before the expiration of 6 months from the filing date of the application. If 6 months has lapsed
`from the filing date of this application and the licensee has not received any indication of a secrecy order under 35
`U.S.C. 181, the licensee may foreign file the application pursuant to 37 CFR 5.15(b).
`
`
`
`SeIectUSA
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location for
`business investment, innovation, and commercialization of new technologies. The U.S. offers tremendous resources
`and advantages for those who invest and manufacture goods here. Through SeIectUSA, our nation works to
`promote and facilitate business investment. SeIectUSA provides information assistance to the international investor
`community; serves as an ombudsman for existing and potential investors; advocates on behalf of U.S. cities, states,
`and regions competing for global investment; and counsels U.S. economic development organizations on investment
`attraction best practices. To learn more about why the United States is the best country in the world to develop
`technology, manufacture products, deliver services, and grow your business,visit or call
`+1-202-482-6800.
`
`page3of3
`
`1002A.O00O1O
`
`

`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES Dm’AR'I‘MENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.0. Box 1450
`Alexandria. Virginia 22313-1450
`WWVl.\lS‘pI0.g(W
`
`NOTICE OF ALLOWANCE AND FEE(S) DUE
`
`826
`ALSTON & BIRD LLP
`BANK OF AMERICA PLAZA
`101 SOUTH TRYON STREET, SUI’I'E 4000
`CHARLOTTE, NC 28280-4000
`
`04/04/2013
`
`Mm
`men, mm
`
`km
`
`DATE MAILED: 04/04/2013
`
`13/132,996
`
`08/17/2011
`
`Guy Derricu
`
`033339/406015
`
`9615
`
`TITLE OF INVENTION: Pharmaceutical Composition Containing An N—Phenylpyraz.ole Derivative, And Use Thereof For Preparing A Topical Veterinary
`For Flea Control
`
`uonprovisional
`
`UNDISCOUNTED
`
`‘SSUEFEEDUE
`$1780
`
`P“w°ATI°"FEEDUE PREV-PAWSUEFEE
`$300
`$0
`
`T°mFEE<S>D“E
`$2080
`
`07/05/2013
`
`THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT.
`PRQSEQIITIQN QN THE MERITS IS QQLQSED. THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS.
`THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON
`PETITION BY THE APPLICANT. SEE 37 CFR 1.313 AND MPEP 1308.
`
`THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAID WITHIN THREE MONTHS FROM THE
`MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED.
`THIS
` . SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES
`NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION.
`IF AN ISSUE FEE HAS
`PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM
`3/[ILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW
`E.
`
`HOW TO REPLY TO THIS NOTICE:
`
`1. Review the ENTITY STATUS shown above. If the ENTITY STATUS is shown as SMALL or MICRO, verify whether entitlement to that
`entity status still applies.
`
`If the ENTITY STATUS is the same as shown above, pay the TOTAL FEE(S) DUE shown above.
`
`If the ENTITY STATUS is changed from that shown above, on PART B - FEE(S) TRANSMI'I'I‘AL, complete section number 5 titled
`"Change in Entity Status (from status indicated above)".
`
`For purposes of this notice, small entity fees are 1/2 the amount of undiscounted fees, and micro entity fees are 1/2 the amount of small entity
`fees.
`
`II. PART B - FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office
`(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required). If you are charging the fee(s) to your deposit account, section "4b"
`of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted. If an equivalent of Part B is filed, a
`request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing
`the paper as an equivalent of Part B.
`
`III. All communications regarding this application must give the application number. Please direct all communications prior to issuance to
`Mail Stop ISSUE FEE unless advised to the contrary.
`
`IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of
`maintenance fees. It is patentee‘s responsibility to ensure timely payment of maintenance fees when due.
`
`PTOL-85 (Rev. 02/1 1)
`
`Pa e 1 of4
`100§A.00oo1 1
`
`

`
`PART B - FEE(S) TRANSMITTAL
`
`Complete and send this form, together with applicable t'ee(s), to: Mail Mail Stop ISSUE FEE
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`(571)-273-2885
`
`or Ea;
`
`CURREVT CORRESPONDDICE ADDRESS (Now: Us: Block lforanychanxe ofaddrets)
`
`through 5 should be completed where
`INSTRUCTIONS: This form should be_ used_for transmitting the ISSUE FEE and PUBLICATION FEE (if required . Blocks 1
`ap
`pnate. All further correspondence including the Patent, advance orders and notification of maintenance fees will
`mailed to the current cones
`ndence address as
`in
`icated unless corrected below or directed otherwise in Block 1. by (a) specifying a new correspondence address; and/or (b) indicating a separate " E ADDRESS" for
`maintenance fee notifications.
`Note: A certificate of mailin can only be used for domestic mailings of the
`Fee(s) Transmittal. This certi icate cannot be used for any other accompanying
`Eapers. Each additional paper, such as an assignment or formal drawing, must
`ave its own certificate of mailing or transmission.
`Certificate of Mailing or Transmission
`thatthi F
`T
`‘teal’ b’
`d
`'ted
`Ih b
`rt‘
`‘unit U 'ted
`SESEE etffat‘ dervifiamvlvistsh? :Sn§e:J§E?‘p‘éF“sfi1tEge‘§i.;:%.’i§t §‘:§§§‘nn1:§. an gnvenlloglae
`'
`t
`a
`3.
`ss
`to
`'
`ac '
`,
`traiisrnitted to tn: USPTO (£71) 273-2885, tin thesgate invtiicftred belgw. Sm 3
`
`CHARLOTTE, NC 28280-4000
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVBVTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`033339/406015
`Guy Derrieu
`08/17/2011
`I3/132,996
`TITLE OF INVENTION: Pharmaceutical Composition Containing An N—Phenylpyrazole Derivative, And Use Thereof For Preparing A Topical Veterinary
`For Flea Control
`
`9615
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUEFEE DUE
`
`PUBLICATION FEE DUE PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovi sional
`
`UNDISCOUNTED
`
`$1780
`
`$300
`
`$0
`
`52080
`
`07/05/2013
`
`CW5-SUMASS
`514—407000
`2. For printing on the patent front page, list
`
`
`1. Change of correspondence address or indication of "Fee Address“ (37
`CPR 1.363).
`(I) the names of up to 3 registered patent attorneys 1
`or agents OR. alternatively,
`ndence address (or Change of Correspondence
`D Chan e of corres
`
`Address orm PTOI
`/I22) attached.
`(2) the name of a single firm (having as a member a
`registered attorney or agent) and the names of up to
`0 "Fee Address" indication (or "Fee Address“ Indication form
`2 registered patent attorneys or agents. If no name is
`PTO/SB/47; Rev 03-02 or more recent) attached. Use of a Customer
`listed, no name will be printed.
`Number is required.
`
`
`
`
`NEAGU, IRINA
`
`1627
`
`
`
`2
`3
`
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`
`PLEASE NOTE: Unless an assi nee is identified below, no assignee data will appear on the patent. If an assignee is identified below. the document has been filed for
`recordation as set forth in 37 C
`3.11. Completion of this form is NOT a substitute for filing an assignment.
`(A) NAME OF ASSIGNEE
`(B) RESIDBWCE: (CITY and STATE OR COUNTRY)
`
`Please check the appropriate assignee category or categories (will not be printed on the patent) : D Individual D Corporation or other private group entity [:1 Government
`
`4b. Payment of Fee(s): (Please first reapply any previously paid issue fee shown above)
`4a. The following fee(s) are submitted:
`D A check is enclosed.
`D Issue Fee
`El Payment by credit card. Form PTO-2038 is attached.
`Cl Publication Fee (No small entity discount permitted)
`I] Advance ()1-def . # of Copies
`UThe Director is hereby authorized to charge the required fee(s). any deficiency. or credit any
`overpayment, to Deposit Account Number _________ (enclose an extra copy of this form).
`
`
`PTOL—85 (Rev. 02/1 1)
`
`Pa e 2 of 4
`1oo§A.oooo12
`
`32‘
`759°
`ALSTON & BIRD LLP
`BANK OF AMERICA PLAZA
`101 SOUTH TRYON STREET, SUITE 4000
`
`°4’°4’2°‘3
`
`

`
`5. Change in Entity Status (from status indicated above)
`Absent:1valid certification of l\/lie? Entgtg Status gsee Spun 1:1‘?/SB/115A andb15B , issue
`D Applicant certifying micro entity status. See 37 CFR 1.29
`ee payment in
`e micro entity amount wi not
`accept: at
`e ris o app ‘cation a an onment.
`Ifttiliiie atriiplicattilon was prtiiatiiiously tinder rrucroifntignsmtus, checking this box will be taken
`D Applicant asserting small entity status. See 37 CFR 1.27
`ano
`ca ono oss 0 en
`emen omicroen y s
`s.
`LLQLE; Checking this box will be taken to be a notification of loss of entitlement to small or micro
`D Applicant changing to regular undiscounted fee status.
`entity status, as applicable.
`NOTE: The Issue Fee and Publication Fee (if required) will not be accepted from anyone other than the applicant; a registered attorney or agent; or the assignee or other party in
`interest as shown by the records of the United States Patent and Trademark Office.
`
`0
`
`Authorized Signature
`
`Date
`
`
`
`Typed or printed name Registration No.
`
`This collection o in ormation is required by 37 CFR 1.311. The information is re uired to obtain or retain a benefit by the public which is to file (and by the USPTO to process)
`an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14.
`'s collection is estimated to take 12 minutes to complete. including gathering. preparing, and
`submitting the coripleted application form to the USFTO. Time will V
`dc ndin upon the individual case. Any comments on the amount of time you require to complete
`this form and/or sujglgestions for reducing this burden. should be sent to e C 'ef In orniation Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce,
`.0.
`Box 1450. Alexan
`ii. Virginia 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450.
`Alexandria. Virginia 22313-1450.
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`PTOL-85 (Rev. 02/ l 1) Approved for use through 08/31/2013.
`
`3.8. Patent and Trademark Ofiice; U.S. DEPARTMENT OF COMMERCE
`
`Page 3 of4
`
`

`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTNIENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 14-50
`Alexandria. Virginia 22313-1450
`www.uspt.o.gcv
`
`13/132,996
`
`08/17/201 1
`
`Guy Derrieu
`
`033339/406015
`
`9615
`
`ALSTON & BIRD LLP
`BAN